Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
This grant opportunity supports research studies in rare diseases using preclinical models to show the potential of new treatments. It provides funding for studies on how the drugs work and how they are processed in the body, with the aim of advancing projects to attract more investment for further drug development or clinical trials.
The NIH supports research on a broad range of diseases that are defined as rare; that is, diseases affecting fewer than 200,000 individuals in the United States. While individually, each rare disease affects a limited number of individuals, when viewed collectively, rare diseases represent a sig…
Funding Source
Awards & funding
Eligibility
Non-domestic (non-U.S.) entities (foreign organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are NOT eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (must be completed…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers